Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Miette

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Clinics and Research in Hepatology and Gastroenterology|September 17, 2011
The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using FibroscanM Sasso, V Miette, L Sandrin, et al.
Ultrasound in Medicine & Biology|May 12, 2009
Copolymer-in-oil phantom materials for elastographyJ Oudry, C Bastard, V Miette, et al.
Clinical Nutrition ESPEN|May 4, 2020
Diagnostic of hepatic fibrosis with the XL probe of the Fibroscan versus biopsies in patients candidates to bariatric surgeryC Barsamian, C Carette, M Sasso, et al.
Journal of Viral Hepatitis|March 13, 2012
Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan(®): validation in chronic hepatitis CM Sasso, I Tengher-Barna, M Ziol, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Clinics and Research in Hepatology and Gastroenterology|September 17, 2011
The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using FibroscanM Sasso, V Miette, L Sandrin, et al.
Ultrasound in Medicine & Biology|May 12, 2009
Copolymer-in-oil phantom materials for elastographyJ Oudry, C Bastard, V Miette, et al.
Clinical Nutrition ESPEN|May 4, 2020
Diagnostic of hepatic fibrosis with the XL probe of the Fibroscan versus biopsies in patients candidates to bariatric surgeryC Barsamian, C Carette, M Sasso, et al.
Journal of Viral Hepatitis|March 13, 2012
Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan(®): validation in chronic hepatitis CM Sasso, I Tengher-Barna, M Ziol, et al.
Pageof 1